Acne Vulgaris

Search with Google Search with Bing
Information
Disease name
Acne Vulgaris
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT05838534 Active, not recruiting Microbiome Comparison Profile of Normal Skin and Acne Vulgaris Patients January 17, 2023 May 24, 2023
NCT02713607 Active, not recruiting Phase 1/Phase 2 Lipidome and Microbiome Profile of Acne March 2016 January 2027
NCT06415305 Active, not recruiting Phase 4 A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne September 1, 2023 December 2024
NCT06336629 Active, not recruiting Phase 4 A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne November 15, 2023 October 2024
NCT06415279 Active, not recruiting Phase 4 A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients February 29, 2024 April 2025
NCT06336603 Active, not recruiting Phase 4 A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne November 15, 2023 September 2024
NCT05497323 Active, not recruiting Phase 1 Effectivity and Safety of Combination Cream of Salicylic Acid, Aqua Posae Filiformis, Niacinamide, Lipohydroxy Acid, Procerad and Zinc PCA August 1, 2022 May 1, 2023
NCT05218486 Active, not recruiting Phase 4 Effect of Oral Isotretinoin on The Level of SerumYKL40 in Acne Vulgaris Patients August 1, 2021 September 30, 2022
NCT06181838 Active, not recruiting N/A Comparison of Quality of Life in Moderate Acne Vulgaris Patients Based on Acne-QoL-INA Using Standard Therapy With and Without Acne Lesions Extraction August 28, 2023 January 3, 2024
NCT05855629 Active, not recruiting N/A "A Comparative Clinical Evaluation of the Efficacy of Topical Adapalene, Benzoyl Peroxide Gel, Oral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin Capsule, and Their Fixed Combination in Mild to Moderate Acne Vulgaris Patients." February 18, 2022 July 30, 2023
NCT05919810 Active, not recruiting N/A The Effects of Oral Probiotics and Herbal Supplementation on the Gut Microbiome and Sebum Excretion Rate in Non-Cystic Acne July 3, 2023 July 31, 2024
NCT04466527 Active, not recruiting N/A Laser Treatment of Moderate to Severe Acne Vulgaris May 20, 2021 December 2024
NCT00355485 Completed Phase 2 Microdermabrasion for Acne September 2006 July 2007
NCT00361322 Completed Phase 1/Phase 2 Efficacy and Safety of a Preparation Containing an Antibiotic and Anti-Inflammatory Agent in Acne Vulgaris April 2005 January 2006
NCT00377000 Completed Phase 4 A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels. November 2005 March 2006
NCT00417456 Completed N/A The Development and Evaluation of an "E-Visit" Program for the Management of Acne October 2005 December 2007
NCT00421993 Completed Phase 3 A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris October 2006 December 2007
NCT00422240 Completed Phase 3 Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris June 27, 2006 July 12, 2007
NCT00441415 Completed Phase 3 Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris February 2007 October 2007
NCT00446043 Completed Phase 3 Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjects February 17, 2004 May 23, 2005
NCT00469755 Completed Phase 4 Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne February 2006 September 2006
NCT00525499 Completed Phase 2 A Phase 2 Study of ASC-J9 Cream in Acne Vulgaris August 2007 July 2008
NCT00558831 Completed N/A Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris October 2007 January 2008
NCT00594425 Completed Phase 2 Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne February 2007 September 2008
NCT00598832 Completed Phase 3 Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1% November 2007 November 2008
NCT00599521 Completed Phase 3 Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1% November 2007 December 2008
NCT00612573 Completed Phase 2 Treatment of Moderate to Severe Facial Acne Vulgaris February 2008 December 2008
NCT00624676 Completed N/A Efficacy and Tolerance of a Derivative of Salicylic Acid and 5% Benzoyl Peroxide in Facial Acne Vulgaris January 2006 August 2006
NCT00635609 Completed Phase 4 Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate March 2008 September 2008
NCT00651469 Completed Phase 3 Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne. January 2003 July 2004
NCT00656981 Completed Phase 3 Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne January 2003 June 2004
NCT00658112 Completed Phase 4 Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne July 2006 May 2008
NCT00660985 Completed Phase 4 Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1% May 2008 November 2008
NCT00663286 Completed Phase 3 A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris October 2006
NCT00664248 Completed Phase 3 A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris October 2006
NCT00666900 Completed Phase 2 A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris January 2008 September 2009
NCT00671749 Completed Phase 4 Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris December 2007 August 2008
NCT00673933 Completed Phase 2 Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris May 2008 December 2008
NCT00689117 Completed Phase 3 A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel April 2008 May 2009
NCT00696449 Completed Phase 4 Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris June 2006 October 2009
NCT00706433 Completed Phase 2 Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne March 2007 July 2008
NCT00713609 Completed Phase 2 Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne June 2008 March 2009
NCT00714454 Completed N/A 5% Sodium L-Ascorbyl-2-Phosphate Lotion for the Treatment of Acne Vulgaris
NCT00714714 Completed Phase 4 Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face. January 2008 February 2008
NCT00722761 Completed Phase 3 Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne April 2009 April 2012
NCT00752635 Completed Phase 4 Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris September 2004 September 2005
NCT00757523 Completed Phase 4 Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris September 10, 2008 June 24, 2009
NCT00767104 Completed N/A Efficacy of Silk - Like Bedding Fabric Pillow Case in the Treatment of Acne Vulgaris October 2008 March 2009
NCT00776919 Completed Phase 3 Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne October 2008 September 2009
NCT00787943 Completed N/A Study of Two Different 10.0% Benzoyl Peroxide Creams for Mild to Moderate Acne Vulgaris May 2008 January 2009
NCT00795327 Completed N/A Injectable POLY-L-Lactic Acid for Treatment of Hill and Valley Acne Scarring October 2008 September 2009
NCT00807014 Completed Phase 4 Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne November 2006 August 2008
NCT00818519 Completed Phase 3 GA YAZ ACNE in China Phase III December 2008 May 2010
NCT00834210 Completed Phase 4 Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris December 2008 September 2009
NCT00835198 Completed Phase 4 Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris December 2008 August 2009
NCT00838812 Completed Phase 3 Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate March 2009 April 2010
NCT00848744 Completed N/A Comparison of Two Salicylic Acid Formulations February 2008 August 2008
NCT00887484 Completed Phase 4 A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne February 2009 June 2009
NCT00891982 Completed Phase 3 A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash April 1, 2009 June 5, 2009
NCT00907257 Completed Phase 4 A Study of Different Use Regimens Using Two Acne Treatments February 2009 September 2009
NCT00907335 Completed Phase 2 A Study of Acne Treatment in Children Ages 9 to 11 February 2009 December 2009
NCT00919191 Completed Phase 4 Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face April 2009 May 2009
NCT00926367 Completed Phase 4 Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications May 2009 July 2009
NCT00933543 Completed Phase 2 Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT) August 2009 March 2010
NCT00952523 Completed Phase 4 Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face July 2009 October 2009
NCT00964223 Completed Phase 4 A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne July 2009 November 2009
NCT00964366 Completed Phase 4 Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications July 2009 August 2009
NCT00991198 Completed Phase 2 The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage September 2009 January 2010
NCT01014689 Completed Phase 3 Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris August 2009 May 2010
NCT01015638 Completed Phase 4 Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications August 2009 September 2009
NCT01016977 Completed Phase 4 A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris October 2009 April 2010
NCT01017120 Completed Phase 3 A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne October 1, 2009 November 9, 2010
NCT01017146 Completed Phase 3 A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301 October 2009 November 2010
NCT01019603 Completed Phase 1 A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris October 12, 2009 December 20, 2009
NCT01038869 Completed Phase 4 Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH) December 2009 May 2010
NCT01040390 Completed Phase 1 Efficacy of Lappa Arctium (Homoeopathic Medicine) in Treatment of Acne Vulgaris March 2010 December 2011
NCT01044264 Completed N/A Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations December 2007 September 2008
NCT01047189 Completed Phase 4 Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris March 2009 October 2009
NCT01050465 Completed N/A MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use May 2009 December 2010
NCT01052246 Completed N/A Pulsed Dye Laser Treatment of Acne Vulgaris October 2008 September 2009
NCT01095640 Completed N/A Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel March 2009 December 2009
NCT01112787 Completed Phase 1 A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers March 26, 2010 April 26, 2010
NCT01114841 Completed Phase 1 A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers March 31, 2010 June 26, 2010
NCT01115322 Completed Phase 1 A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers April 1, 2010 April 10, 2010
NCT01119651 Completed Phase 1 A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers. June 14, 2010 June 26, 2010
NCT01132443 Completed Phase 1 W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne May 6, 2010 June 12, 2010
NCT01138514 Completed Phase 3 Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels October 2009 October 2010
NCT01149330 Completed Phase 4 Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris July 2010 April 2011
NCT01160757 Completed Phase 1 A Study to Determine the Safety and Efficacy of an Ultrasound Device in the Management of Acute Acne Lesions October 2008
NCT01160848 Completed Phase 2 Photoactive Porphyrins (PAP) Levels After Topical Visonac Application in Acne Patients August 2010 January 2011
NCT01176955 Completed N/A A Novel Method to Improve Acne Outcomes May 2009 August 2010
NCT01179633 Completed Phase 1/Phase 2 Acne Treatment With Active Patches Which Contains Azelaic Acid, Citric Acid,Salicylic Acid and 2% Ascorbic Acid March 2010 June 2010
NCT01180543 Completed Phase 2 Acne Treatment With Active Oplon's Patches August 2010 December 2010
NCT01182636 Completed Phase 1 Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris July 2007 April 2008
NCT01188538 Completed Phase 4 Anti Propionibacterium(P.) Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel March 2010 August 2010
NCT01194375 Completed Phase 2 A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris September 2010 December 2011
NCT01209949 Completed Phase 4 Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris October 2010 January 2011
NCT01231334 Completed Phase 4 A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne August 2010 June 2011
NCT01237821 Completed N/A Comparing OTC Acne Treatment to Prescription Regimen October 2010 October 2011
NCT01241331 Completed Phase 2 BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris November 2010
NCT01293552 Completed Phase 2 Clinical Trial To Evaluate ANT-1207 In Subjects With Acne January 2011 July 2012
NCT01313728 Completed Phase 4 A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products December 2010 January 2011
NCT01320033 Completed Phase 2 Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris March 29, 2011 January 3, 2012
NCT01321632 Completed Phase 1 Efficacy of Zingiber Officinalis (Homoeopathic Medicine) in Treatment of Acne Vulgaris March 2011 July 2012
NCT01321645 Completed Phase 1 Efficacy of Azadirachta Indica (Homoeopathic Medicine) in Treatment of Acne Vulgaris March 2011 June 2012
NCT01326780 Completed Phase 2 A Study of a New Drug Treatment for Acne March 31, 2011 March 31, 2012
NCT01347879 Completed Phase 2 A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi-center Study of Photodynamic Therapy With Visonac® Cream in Patients With Acne Vulgaris May 2011 May 2012
NCT01362010 Completed Phase 2 Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients January 2012 July 2013
NCT01387048 Completed Phase 4 Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin August 2011 October 2012
NCT01400932 Completed Phase 3 Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects July 2011 April 2012
NCT01404130 Completed Phase 4 A Pilot Study of the Effects of Isotretinoin on Cognition, Learning and Memory September 2008 November 2010
NCT04214652 Completed Phase 3 Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris January 27, 2020 March 18, 2021
NCT00110643 Completed Phase 2/Phase 3 Infrared Non-Cutting Laser Therapy for Acne February 2003 December 2005
NCT00113425 Completed Phase 2 Non-cutting Laser Therapy in the Treatment of Acne August 2005 November 2008
NCT00145106 Completed Phase 4 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris March 2002 August 2002
NCT00151541 Completed Phase 3 A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4% February 2005 July 2005
NCT00160394 Completed Phase 4 Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris December 2004 August 2005
NCT00206895 Completed N/A Photodynamic Therapy of Acne Vulgaris - a Randomized Blinded Controlled Study November 2004
NCT00211497 Completed Phase 2 Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne January 2003 September 2003
NCT00211523 Completed Phase 2 Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne October 2000 September 2001
NCT00219570 Completed Phase 4 Dalacin-T Gel Post Approval Study January 2005 June 2005
NCT00243542 Completed Phase 4 Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency November 2005 October 2006
NCT00280657 Completed Phase 3 Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa March 10, 2004 May 21, 2005
NCT03402893 Completed Phase 4 The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color July 28, 2017 February 28, 2018
NCT03411733 Completed Prevalence of H.Pylori in Patients With Acne Vulgaris Acne Vulgaris March 1, 2017 March 1, 2018
NCT03427554 Completed Early Phase 1 To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne Vulgaris August 21, 2017 January 26, 2018
NCT03433378 Completed Early Phase 1 To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris August 4, 2017 January 26, 2018
NCT03450369 Completed Phase 1 A Study of the Safety, Engraftment, and Action of NB01 in Adults With Moderate Acne January 24, 2018 June 18, 2018
NCT03522441 Completed Phase 3 Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris April 27, 2018 April 22, 2019
NCT03522922 Completed Phase 1/Phase 2 Efficacy of Microneedling With Topical Vitamin C in Treatment of Acne Scarring June 1, 2016 March 31, 2018
NCT03524040 Completed N/A Imaging of Pilosebaceous Units and Acne Lesions by RCM and OCT Confocal Microscopy and Optical Coherence Tomography December 2016 January 2018
NCT03536637 Completed Phase 2 DMT310-001 Topical in the Treatment of Acne Vulgaris May 22, 2018 January 28, 2019
NCT03573115 Completed N/A Multimodal Optical Imaging for Pretreatment Evaluation for Cutaneous Microparticle Delivery January 4, 2018 August 1, 2020
NCT03573518 Completed Phase 2 Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris June 26, 2018 September 5, 2019
NCT03585140 Completed N/A Low Glycemic Index and Load Diet for the Treatment of Acne January 1, 2016 November 30, 2016
NCT03599193 Completed Phase 2 A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris October 4, 2017 April 30, 2018
NCT03615768 Completed Phase 3 A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris August 14, 2018 April 7, 2020
NCT03626298 Completed Phase 4 Efficacy and Tolerability of Nicotinamide Plus Cream for Moderate Acne Vulgaris in Indonesia August 1, 2016 April 30, 2018
NCT03650361 Completed Phase 3 Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris September 17, 2018 February 16, 2019
NCT03653403 Completed Phase 1 Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel August 8, 2018 June 19, 2019
NCT03664739 Completed Phase 3 Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris December 5, 2018 March 23, 2020
NCT03664752 Completed Phase 3 Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris December 10, 2018 May 7, 2020
NCT03681470 Completed Phase 4 Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color April 9, 2019 May 6, 2021
NCT03709654 Completed Phase 1 A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne November 1, 2018 September 30, 2019
NCT03717506 Completed Phase 3 Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris October 10, 2018 April 16, 2020
NCT03743038 Completed Phase 1 A Study Comparing Two Topicals in the Treatment of Acne Vulgaris November 20, 2018 February 11, 2019
NCT03761784 Completed Phase 3 A Study of S6G5T-3 in the Treatment of Acne Vulgaris December 21, 2018 December 31, 2019
NCT03761810 Completed Phase 3 A Study of S6G5T3 in the Treatment of Acne Vulgaris December 14, 2018 October 23, 2019
NCT03878238 Completed N/A A Pilot Study to Evaluate the Effect of a Probiotic Mixture in Acne July 11, 2018 May 29, 2019
NCT03915860 Completed Phase 3 Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris March 27, 2019 December 23, 2019
NCT03933033 Completed N/A Erbium-YAG Laser Versus Platelet Rich Plasma in the Treatment of Atrophic Acne Scars June 1, 2017 February 28, 2019
NCT04002024 Completed N/A Moisturizer Containing Licochalcone A, Decanediol, L-carnitine and Salicylic Acid in Reducing Relapsing of Acne June 1, 2019 May 1, 2020
NCT04015375 Completed Phase 3 Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris July 11, 2019 February 22, 2020
NCT04018885 Completed Phase 1/Phase 2 A Study on Safety and Preliminary Efficacy of ALA in Acne Vulgaris July 11, 2019 January 20, 2020
NCT04044898 Completed Phase 1 Pharmacokinetics and Safety of ALA in Acne Vulgaris January 12, 2021 December 6, 2021
NCT04056598 Completed Acne Vulgaris Related Microbiology and Serology January 18, 2018 September 30, 2019
NCT04059523 Completed Phase 1 MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3 June 27, 2019 February 6, 2020
NCT04104685 Completed Phase 2 A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam. September 18, 2019 March 3, 2020
NCT04106778 Completed Phase 2 DMT310-003 Topical in the Treatment of Acne Vulgaris October 10, 2019 May 4, 2020
NCT04118296 Completed Phase 1/Phase 2 Decreasing Severity of Acne Vulgaris After the Use of a Combination of Anti-Acne Cream October 8, 2019 November 30, 2019
NCT04134273 Completed Phase 1 Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris March 20, 2019 October 15, 2019
NCT04156815 Completed N/A Treatment of Acne Vulgaris Using NAFL in Combination With Isotretinoin and Pricking Blood Therapy July 5, 2018 October 5, 2018
NCT04206631 Completed Phase 1 Comedone Extraction and Oral Doxycycline In The First Line Treatment of Moderate Acne Vulgaris April 1, 2015 October 14, 2015
NCT04214639 Completed Phase 3 Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris January 17, 2020 January 18, 2021
NCT00031096 Completed Phase 3 Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne January 2002 July 2002
NCT04216160 Completed N/A Skin Acceptance and Efficacy Assessment of a Topical Product in Acne Treatment When Compared to a Placebo. May 5, 2019 February 11, 2020
NCT04301063 Completed Assess the Effects and the Tolerance of Cosmetic Product in the Follow-up Phase of Facial Acne for 1 Year February 4, 2019 May 6, 2020
NCT04321070 Completed Phase 1 Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris September 9, 2019 March 6, 2020
NCT04367584 Completed Comparison of Malassezia Spp Proportions in Inflammatory and Non Inflammatory Facial Acne Vulgaris Lesions October 1, 2018 December 30, 2018
NCT04451330 Completed Phase 4 A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV) July 29, 2020 April 26, 2021
NCT04538729 Completed Use of Alternative Therapy in Acne Vulgaris Patients March 1, 2020 November 30, 2020
NCT04555018 Completed Correlation Between Dehydroepiandrosterone Sulfate and Sebum Level in Adult Female Acne Vulgaris June 1, 2017 October 1, 2017
NCT04570319 Completed N/A Clinical Trial to Evaluate the Effect of a Probiotic in Acne April 29, 2020 September 20, 2022
NCT04593004 Completed N/A Teledermatology vs. Face-to-Face Visits in the Follow-Up of Patients With Acne October 7, 2020 June 20, 2022
NCT04594759 Completed Phase 1/Phase 2 Weekly Isotretinoin Therapy Study November 11, 2020 December 21, 2021
NCT04631250 Completed N/A Conventional Photodynamic Therapy Versus Daylight Photodynamic Therapy for The Treatment of Acne Vulgaris November 1, 2018 July 1, 2020
NCT04695691 Completed N/A A Device Study for the Treatment of Acne December 15, 2020 December 7, 2022
NCT04698239 Completed N/A Clinical Evaluation of the Safety and Benefits of the Milesman 445 nm Blue Laser on Inflammatory Acne Lesions. September 24, 2020 February 15, 2021
NCT04709289 Completed N/A Adverse Effects of ALA-PDT for the Treatment of Moderate to Severe Acne Vulgaris: a Prospective Study January 1, 2020 February 28, 2020
NCT04724473 Completed Early Phase 1 A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris December 10, 2019 November 21, 2020
NCT04797793 Completed Early Phase 1 A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris May 18, 2020 January 8, 2021
NCT04820673 Completed Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES) May 24, 2021 May 4, 2022
NCT04856904 Completed Phase 4 Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation May 28, 2021 June 30, 2023
NCT04856917 Completed Phase 2 A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris May 15, 2021 March 29, 2022
NCT04883736 Completed Early Phase 1 A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris August 31, 2020 April 16, 2021
NCT04892706 Completed Phase 2 Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel June 11, 2021 September 28, 2022
NCT04899843 Completed Phase 2 Effectiveness of Zinc Supplementation With Topical Retinoids in Acne Vulgaris Patients April 27, 2021 November 30, 2021
NCT04937374 Completed N/A Efficacy and Tolerability of Rehmannia Glutinosa Leaf Extract in the Treatment of Acne Vulgaris June 5, 2021 October 4, 2021
NCT04940767 Completed Phase 4 A Companion Treatment Study for Patients With Moderate to Severe Acne Vulgaris June 28, 2021 April 28, 2023
NCT04943159 Completed Phase 2 Afamelanotide in Patients Suffering With Acne Vulgaris August 24, 2010 March 8, 2011
NCT04949932 Completed N/A Application of Poly-herbal Powder for Treating Acne Vulgaris April 3, 2021 May 12, 2021
NCT04960930 Completed Phase 3 To Evaluate the Efficacy and Safety of Minocycline Hydrochloride Foam in the Treatment of Moderate-to-severe Acne Vulgaris September 17, 2021 October 14, 2022
NCT04975412 Completed Relationship of Whole Blood Zinc Levels to Acne Severity November 27, 2017 March 16, 2018
NCT05010538 Completed Sarecycline Truncal Acne Safety and Efficacy Response March 9, 2021 August 31, 2021
NCT05012735 Completed Phase 1 A Study of a Hydrocolloid Bandage on Pimples July 19, 2021 September 13, 2021
NCT05071274 Completed N/A A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Microneedling With SkinPen in Female and Male Subjects With Facial Acne Vulgaris, Ages 18 Through 45 March 15, 2021 March 18, 2022
NCT05089708 Completed Phase 4 AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation December 22, 2021 December 15, 2022
NCT05094700 Completed N/A A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin Participants October 25, 2021 November 30, 2021
NCT05096312 Completed Phase 4 Effects of Oral Zinc Gluconate Among Acne Vulgaris Patients December 21, 2018 July 20, 2019
NCT05104125 Completed Phase 2 Study to Evaluate the Safety and Efficacy of ASC40 in Subjects With Moderate to Severe Acne Vulgaris January 12, 2022 April 10, 2023
NCT05131373 Completed Phase 1 Safety, Tolerability, and Immunogenicity of ORI-A-ce001 for the Treatment of Acne Vulgaris September 28, 2021 November 27, 2023
NCT05216289 Completed Phase 4 The Efficacy of an Oral Probiotic Associated With a Fixed Combination of Benzoyl Peroxide and Adapalene in the Treatment of Acne April 1, 2018 April 1, 2021
NCT05345093 Completed N/A Evaluation of Safety and Performance of Ialuxid Gel in Treatment of Acne Vulgaris, and Folliculitis November 11, 2022 September 22, 2023
NCT05398939 Completed Impact of COVID-19 Vaccination on Serum 25-hydroxyvitamin D Level May 25, 2022 November 29, 2022
NCT05399290 Completed Phase 4 Subantimicrobial Doxycycline in Acne November 19, 2020 November 8, 2021
NCT05413200 Completed Investigation of the Effect of Oral Isotretinoin on Skin Thickness and Elasticity in Patients With Atrophic Acne Scar November 1, 2021 June 4, 2022
NCT05428449 Completed Phase 1 Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029 February 10, 2022 April 6, 2023
NCT05457621 Completed N/A Effectiveness and Tolerance of Effaclar Serum in Women With Mandibular Acne January 21, 2021 July 8, 2021
NCT05529888 Completed Phase 4 Measure the Serum Level of Homocysteine in Acne Patients Before and After Oral Isotretinoin. December 15, 2020 December 15, 2021
NCT05550337 Completed Phase 3 Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne Vulgaris September 19, 2022 May 9, 2023
NCT05622253 Completed N/A Combined Low-Dose Isotretenion and Long-Pulsed 1064 ND-YAG Laser in the Treatment of Acne Erythema March 1, 2022 December 1, 2022
NCT05629468 Completed Phase 3 Comparing Efficacy of Azithromycin and Probiotics for Treatment of Acne Vulgaris October 15, 2021 August 31, 2022
NCT05684861 Completed Phase 2 Serum TWEAK Levels in Acne Vulgaris January 1, 2022 January 1, 2023
NCT05704114 Completed Phase 4 Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne February 1, 2021 May 1, 2022
NCT05712837 Completed N/A Efficacy of 25% Trichloroacetic Acid Peel Versus 30% Salicylic Acid Peel in Mild to Moderate Acne Vulgaris June 1, 2022 November 30, 2022
NCT05821296 Completed N/A Evaluation of Efficacy and Tolerance of Crystal Peel in the Treatment of Adults Presenting Facial Mild Acne January 23, 2023 June 7, 2023
NCT05839223 Completed N/A Clinical Pharmacist Role in Adherence to Recommendations Among Isotretinoin Users September 1, 2020 February 20, 2021
NCT05926869 Completed Phase 2 Comparison of the Efficacy of Clindamycin Phosphate 1% Gel Versus Once-daily Dapsone 5% Gel in the Treatment of Moderate Acne Vulgaris August 1, 2022 February 1, 2023
NCT05982613 Completed Effectiveness of Standard Therapy of Acne Vulgaris April 18, 2023 June 5, 2023
NCT06004583 Completed C-Reactive Protein/Albumin Ratio and Acne Vulgaris January 5, 2022 May 1, 2023
NCT06063473 Completed Phase 1 A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne Vulgaris February 22, 2023 July 13, 2023
NCT06170593 Completed N/A Intralesional Injections of Triamcinolone for Acne Vulgaris November 15, 2022 February 14, 2023
NCT06179056 Completed Anti-microbial Role of Non-antibiotic Agents Against Cutibacterium Acnes in Patients With Acne Vulgaris March 1, 2023 February 1, 2024
NCT06415292 Completed Phase 4 A Study to Evaluate the Impact of Clacoterone 1% Cream on Skin Barrier Properties in Acne Prone Patients November 27, 2023 December 16, 2023
NCT06451237 Completed Phase 3 Acne Remission Maintenance by Weekend Systemic Isotretinoin January 20, 2018 September 20, 2023
NCT01428466 Completed Phase 1 Japanese Phase 1 Study of GSK2585823 November 18, 2010 February 15, 2011
NCT01445301 Completed Phase 3 Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects September 27, 2011 August 2, 2012
NCT01446237 Completed N/A U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne June 1, 2011 December 15, 2011
NCT01461655 Completed Phase 2 Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris November 2011 May 2012
NCT01466673 Completed Phase 4 An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment December 2008 March 2010
NCT01472900 Completed N/A 2940nm Er:YAG Laser Versus Benzoyl Peroxide Gel for the Treatment of Inflammatory Acne October 2010 April 2012
NCT01474798 Completed Phase 2 Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris February 29, 2012 December 31, 2012
NCT01492647 Completed Phase 1 A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris August 2011 October 2011
NCT01494285 Completed Phase 1/Phase 2 Clinical Study to Evaluate Tolerability and Safety of ARK-E021 Foam and to Monitor Clinical Effect in Acne Vulgaris Patients June 2012 October 2013
NCT01498874 Completed Phase 2 Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris December 2011 June 2013
NCT01501799 Completed N/A A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris July 2011 December 2011
NCT01504204 Completed Phase 4 Effect of Samples on Acne Treatment With Epiduo® Gel December 2011 November 2012
NCT01522456 Completed Phase 4 Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel April 2012 May 2012
NCT01527123 Completed Phase 1 A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris February 28, 2012 June 1, 2012
NCT01556698 Completed Phase 1/Phase 2 Study of NVN1000 Topical Gel and Topical Gel Vehicle in the Treatment of Moderate to Severe Acne Vulgaris July 2011 December 2011
NCT01584674 Completed Phase 3 A Clinical Trial Evaluating the Safety and Efficacy of the KLOX Biophotonic System in Moderate to Severe Acne March 2012 April 2013
NCT01616654 Completed Phase 2 Dose Range Study of CD5789 in Acne Vulgaris June 20, 2012 June 12, 2014
NCT01618773 Completed Long-term Study of Epiduo in Patients With Moderate to Severe Acne June 2012 September 2013
NCT01628549 Completed Phase 2 Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris June 30, 2012 January 31, 2013
NCT01629797 Completed N/A Knowledge Evaluation and Assessment of the Effectiveness of an Education Intervention on Acne May 2012 November 2012
NCT01631474 Completed Phase 2 A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris June 2012 February 2014
NCT01677221 Completed N/A Effects of Acleara Needle Insert on Acne July 2012 January 2013
NCT01682200 Completed Phase 1 Clinical Trial on the Effects and Side Effects of ProOxy in the Treatment of Acne October 2009 September 2011
NCT01687556 Completed N/A EGCG Improves Acne by Modulating Molecular Targets July 2005 June 2006
NCT01689935 Completed Phase 1 Reduced Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne (i-PDT) November 2009 December 2014
NCT01694433 Completed Phase 2/Phase 3 "Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy" February 2013 January 9, 2014
NCT01694810 Completed Phase 1 Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers September 2012 November 2012
NCT01706250 Completed Phase 4 U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™ September 1, 2009 January 25, 2010
NCT01706263 Completed Phase 4 U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne August 1, 2009 November 20, 2009
NCT01727440 Completed Identifying the Genetic Predictors of Severe Acne Vulgaris and the Outcome of Oral Isotretinoin Treatment September 2011 August 2015
NCT01742637 Completed Phase 1 Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris October 2012 March 2014
NCT01755247 Completed Phase 1 A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers November 2012 December 2012
NCT01769235 Completed Phase 1 Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris November 2012 December 2013
NCT01769664 Completed Phase 1 A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris September 2012 August 2013
NCT01773122 Completed Phase 1 Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris January 21, 2013 May 5, 2013
NCT01788384 Completed Phase 3 Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris July 2012 December 2012
NCT01815450 Completed Phase 2 BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris February 2013
NCT01830764 Completed Phase 1 Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers April 2013 June 2013
NCT01831960 Completed Phase 2 An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris April 2013 November 2013
NCT01844739 Completed Phase 1 A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel April 2013 June 2013
NCT01844752 Completed Phase 2 A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne April 2013 November 2013
NCT01880320 Completed Phase 3 Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris July 2013 March 2014
NCT01885910 Completed Phase 4 Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel July 2013 July 2014
NCT01910064 Completed Phase 3 A Long Term Study of GK530G in Subjects With Acne Vulgaris May 2013 August 2014
NCT01915732 Completed Phase 3 A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris April 2013 April 2014
NCT01915758 Completed Phase 1 W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers November 21, 2008 February 20, 2009
NCT01929278 Completed Phase 1 W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers December 8, 2008 December 19, 2008
NCT01930565 Completed N/A Effectiveness and Safety of New Botanical Component-LFCO- Compared With Existing TTO in Clinical Study January 2013 July 2013
NCT01931774 Completed Is Acne a Skin Disease Affecting the Brain Functions? Neurocognition in Patients With Acne Vulgaris April 2013 July 2013
NCT01936324 Completed Phase 1/Phase 2 A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel August 2013 June 2014
NCT01938482 Completed Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029 October 31, 2013 February 17, 2015
NCT01974141 Completed Phase 3 A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris November 2013 October 2014
NCT01974323 Completed Phase 3 Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris November 2013 October 2014
NCT01984801 Completed Phase 1 Study to Investigate the Irritation Potential of GSK1940029 Gel October 14, 2013 April 10, 2015
NCT02005666 Completed Phase 3 To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel November 2013 September 28, 2016
NCT02031718 Completed N/A Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone January 2014 July 2014
NCT02032407 Completed Phase 4 A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris December 2013 September 2014
NCT02058628 Completed Phase 4 Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris February 21, 2014 September 8, 2014
NCT02066545 Completed Phase 2 Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris April 2014
NCT02073448 Completed Phase 3 Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris. March 2014 October 2014
NCT02073461 Completed Phase 2 Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris. March 2014 October 2014
NCT02160678 Completed Phase 3 Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris May 2014 July 2015
NCT02164084 Completed Phase 1 A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris June 2014 December 2014
NCT02189629 Completed Phase 3 CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris February 23, 2015 February 23, 2017
NCT02218034 Completed Phase 1 Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris August 2014 March 2015
NCT02219074 Completed N/A Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris June 2011 October 2016
NCT02242760 Completed Phase 2 P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris November 2014 August 2015
NCT02249104 Completed Phase 4 A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris August 2014 February 2015
NCT02250430 Completed Phase 1 A Phase 1 Study Assessing Local Cutaneous Effects of SB204 September 2014 September 2014
NCT02267746 Completed Phase 3 A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris June 2014 September 2014
NCT02270411 Completed Inflammatory Cells From Various Pathologies May 2014 December 2023
NCT02293018 Completed Phase 1/Phase 2 Pharmacokinetic Study of MTC896 Gel in Subjects With Acne August 2014 January 2015
NCT02320149 Completed Phase 3 Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne December 18, 2014 February 1, 2017
NCT02322866 Completed Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne December 3, 2014 January 12, 2017
NCT02338544 Completed Application of Epiduo(R) PUMP in Daily Practice in Patients With Inflammatory Acne January 2015 September 2015
NCT02349399 Completed Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases May 1, 2015 March 1, 2016
NCT02385760 Completed Phase 2 CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris April 2015 August 2016
NCT02404285 Completed Phase 1/Phase 2 A Study to Evaluate the Clinical Effect of Daily Next Science™ Acne Gel (NAG) on Mild to Moderate Facial Acne March 2015 September 2015
NCT02410031 Completed Risk Minimisation Study for Diane-35 and Its Generics June 26, 2015 March 4, 2016
NCT02411942 Completed Phase 1 Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris August 2014 February 2015
NCT02411955 Completed Phase 1 A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris June 2014 February 2015
NCT02413346 Completed Phase 3 A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris March 20, 2015 August 26, 2016
NCT02431052 Completed Phase 2 A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris April 2015 April 2016
NCT02465632 Completed Phase 3 To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris. April 2015 December 2015
NCT02498288 Completed Phase 1 A Study to Determine Bioequivalence of Isotretinoin in Healthy Male Subjects Under Fed Condition May 31, 2013 July 15, 2013
NCT02524665 Completed Phase 4 8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne September 2009 December 2009
NCT02556788 Completed Phase 3 Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50µg/g Cream Versus Vehicle Cream in Acne Vulgaris November 2015 May 12, 2017
NCT02557399 Completed Phase 4 DUAC® Early Onset Efficacy Study in Japanese Subjects October 7, 2015 February 17, 2016
NCT02566369 Completed Phase 3 Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris November 30, 2015 November 14, 2017
NCT02571998 Completed Phase 2 A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris October 2015 August 2016
NCT02575950 Completed Phase 2 Explorative Trial Evaluating the Efficacy and Tolerability of LEO43204 in Moderate to Severe Acne June 2016 April 2017
NCT02578043 Completed Phase 1 A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris April 2015 September 2015
NCT02581072 Completed Phase 1 A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204 October 2015 April 2016
NCT02589405 Completed Phase 4 Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris August 2015 January 2016
NCT02595034 Completed Phase 1 A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris January 2015 November 2015
NCT02604680 Completed Phase 2 A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris October 2015 June 2016
NCT02608450 Completed Phase 3 A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) January 21, 2016 April 11, 2018
NCT02608476 Completed Phase 3 A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) November 16, 2015 February 21, 2018
NCT02616614 Completed Phase 3 Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris May 2015 November 2015
NCT02620813 Completed Early Phase 1 De Novo Lipogenesis of Sebaceous Glands in Acne October 2015 October 12, 2017
NCT02656043 Completed Phase 1/Phase 2 A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel September 17, 2015 March 17, 2017
NCT02656485 Completed Phase 1/Phase 2 A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris August 5, 2015 July 15, 2016
NCT02661958 Completed Phase 2 Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris May 2016 October 2017
NCT02667444 Completed Phase 3 P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne February 19, 2016 December 9, 2016
NCT02672332 Completed Phase 3 P3 Study in Acne Comparing Once Daily SB204 and Vehicle February 22, 2016 December 21, 2016
NCT02682264 Completed Phase 3 An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris March 9, 2016 August 31, 2018
NCT02698436 Completed N/A A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne. March 31, 2016 August 31, 2016
NCT02709096 Completed Phase 2 BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes April 2016 June 2016
NCT02709902 Completed Phase 1 Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris September 2015 March 2016
NCT02720627 Completed Phase 2 An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris October 28, 2016 March 21, 2018
NCT02721173 Completed Phase 4 Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris April 2016 January 2017
NCT02731105 Completed Phase 4 Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products February 2015 January 2018
NCT02735421 Completed Phase 4 Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars May 13, 2016 November 23, 2017
NCT02774590 Completed Phase 1 Timolol for the Treatment of Acne and Rosacea March 2016 March 2021
NCT02798120 Completed Phase 3 P3 Long Term Safety Study of Once Daily SB204 in Acne May 12, 2016 April 27, 2017
NCT02801903 Completed Phase 1 Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris June 7, 2016 August 25, 2016
NCT02815267 Completed Phase 3 A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne May 2016 October 13, 2017
NCT02815280 Completed Phase 3 A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne May 2016 October 13, 2017
NCT02815332 Completed Phase 2 BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris August 2016 March 24, 2017
NCT02832063 Completed Phase 2/Phase 3 Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris August 2016 July 19, 2017
NCT02865005 Completed Phase 3 Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris February 2016 December 2016
NCT02886715 Completed Phase 3 A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris September 21, 2016 May 31, 2017
NCT02899000 Completed Phase 4 A Treatment for Severe Inflammatory Acne Subjects July 29, 2016 June 27, 2017
NCT02905851 Completed N/A Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris May 2016 May 2018
NCT02913001 Completed N/A The Effect of a Low Glycemic Load Diet on Hormonal Markers Associated With Acne September 2014 November 2015
NCT02929719 Completed Phase 1 Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris April 2014 June 2016
NCT02932267 Completed Phase 3 Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne February 2, 2017 January 10, 2018
NCT02935036 Completed Phase 2 Efficacy Study in Patients With Acne Vulgaris. October 3, 2016 March 21, 2017
NCT02938494 Completed Phase 2 Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris November 2015 September 2016
NCT02946788 Completed Phase 2 Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel March 13, 2017 June 1, 2018
NCT02959970 Completed Phase 4 Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris October 31, 2016 March 9, 2018
NCT02998671 Completed Phase 2 Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne December 22, 2016 August 1, 2018
NCT03003247 Completed Phase 2 Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris November 2015 September 30, 2016
NCT03028363 Completed Phase 3 A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris December 27, 2016 November 28, 2017
NCT03039634 Completed Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA August 2016 May 2018
NCT03071549 Completed Phase 3 Combined Salicylic and Azaleic Acid Verus Trichloroacetic Acid 25% Peel in Treatment of Acne April 2016 November 2016
NCT03073486 Completed Phase 3 A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris February 6, 2017 December 21, 2017
NCT03124381 Completed N/A A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne April 8, 2017 September 6, 2017
NCT03127956 Completed Phase 3 A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris March 21, 2017 April 27, 2018
NCT03128723 Completed N/A A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris April 30, 2017 June 8, 2017
NCT03132194 Completed Phase 1 Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris August 8, 2016 January 30, 2017
NCT03168321 Completed Phase 3 A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301) June 29, 2017 June 7, 2018
NCT03168334 Completed Phase 3 A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302) July 11, 2017 July 24, 2018
NCT03170388 Completed Phase 2 A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris October 5, 2017 April 23, 2019
NCT03192163 Completed Cultural Differences in Treatment Preferences and Perceptions of Acne June 2015 February 2018
NCT03271021 Completed Phase 3 A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris July 17, 2017 September 4, 2018
NCT03290027 Completed Phase 3 A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris July 31, 2017 April 19, 2018
NCT03292640 Completed Phase 3 A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks July 6, 2017 May 14, 2018
NCT03303170 Completed N/A Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris September 25, 2017 April 10, 2018
NCT03307577 Completed Phase 2 A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris October 5, 2017 May 31, 2018
NCT03334682 Completed Phase 3 Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman. January 31, 2018 July 4, 2023
NCT03341910 Completed Phase 2 A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris August 21, 2017 May 18, 2018
NCT03393494 Completed Phase 3 Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face December 13, 2017 January 5, 2019
NCT05758259 Enrolling by invitation Phase 4 The Efficacy and Safety of Topical Vitamin D and Supplementation In Acne Vulgaris The Study of VDR, IL-1β, IL-6, IL-10 and IL-17 Expression February 16, 2023 October 2023
NCT06225570 Not yet recruiting Early Phase 1 Weekly Isotretinoin vs Tetracycline for Moderate Acne January 2025 June 2025
NCT05885217 Not yet recruiting Measurement of Serum microRNA in Acne Vulgaris Patient August 2023 October 2024
NCT05471388 Not yet recruiting N/A Assessment of Serum Asprosin Level in Male Patients With Acne Vulgaris July 18, 2022 January 18, 2023
NCT05666765 Not yet recruiting Phase 4 Comparison Between Isotretinoin, Silymarin and Both in the Treatment of Acne Vulgaris January 1, 2023 January 1, 2024
NCT05783778 Not yet recruiting N/A Evaluation of the Role of Latent Toxoplasmosis in Female Patients With Active Acne Vulgaris June 1, 2023 December 1, 2024
NCT05316675 Not yet recruiting Phase 4 Impact of Isotretinoin in Different Doses on Quality of Life December 2022 December 2024
NCT06158061 Not yet recruiting N/A Assessment of Serum and Tissue Tryptase Levels in Acne Vulgaris Patients January 24, 2024 August 15, 2024
NCT05899699 Not yet recruiting Phase 2 Effect of New Topical Preparation for Treatment of Acne Vulgaris June 5, 2023 October 1, 2023
NCT06142487 Not yet recruiting N/A Assessment of the Effects of Silk Pillowcases on Acne Prone Skin November 10, 2023 November 10, 2023
NCT06141330 Not yet recruiting N/A Vitamin D Supplementation in Acne December 1, 2023 March 2024
NCT06425900 Not yet recruiting Phase 4 A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients July 2024 September 2024
NCT06175819 Not yet recruiting N/A Efficacy of Manuka Honey Nano-Formulation in the Treatment of Acne Vulgaris January 2024 September 11, 2024
NCT06447480 Not yet recruiting Phase 3 Randomized Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients September 1, 2024 September 1, 2027
NCT05869188 Not yet recruiting N/A Effect of Systemic Isotretinoin on Serum Irisin Level in Acne Vulgaris Patients June 1, 2023 January 1, 2024
NCT06454708 Not yet recruiting Phase 1 Pharmacokinetics, Safety and Tolerability of Clascoterone Cream 1% in Healthy Chinese Adult Subjects July 2024 August 2024
NCT06340984 Not yet recruiting Phase 3 Serum Intercellular Adhesion Molecule -1 in Acne Vulgaris Patients : Effect of Montelukast June 2024 February 2025
NCT06237387 Not yet recruiting Association of Acne Vulgaris With Oral Hygiene and Gingivitis June 5, 2024 July 15, 2024
NCT05536193 Not yet recruiting Phase 4 Topical Metformin Emulgel VS Salicylic Acid Peeling in Treatment of Acne Vulgaris September 10, 2022 September 10, 2023
NCT06263413 Recruiting Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions January 15, 2024 September 30, 2024
NCT05903716 Recruiting The Effects of Systemic Isotretinoin Treatment on Adrenal Steroid and Sex Hormones Level in Severe Acne Vulgaris September 15, 2022 June 30, 2023
NCT05269641 Recruiting N/A Almond Supplementation on Mild to Moderate Acne February 28, 2022 December 1, 2024
NCT06281782 Recruiting N/A Platelet-rich Plasma With Topical Retinoids Versus Topical Retinoids Alone in Acne Vulgaris January 1, 2024 May 2024
NCT06403501 Recruiting Phase 3 Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris May 20, 2024 February 2025
NCT05430464 Recruiting N/A A Study of a Laser for the Treatment of Acne Vulgaris July 27, 2022 October 2024
NCT06186596 Recruiting N/A Self-Administered Intralesional Injections for Acne February 1, 2023 January 31, 2024
NCT05069272 Recruiting N/A Double-blinded, Vehicle Controlled Study to Evaluate Efficacy & Tolerance of Bakuchiol and Ethyl Linoleate on Acne September 10, 2021 January 30, 2025
NCT05755256 Recruiting Phase 2 The Impact of Probiotics on Skin Hydration in Youth With Mild Acne September 4, 2023 June 2024
NCT03883269 Recruiting Phase 4 Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients March 20, 2018 December 2019
NCT06252194 Recruiting Phase 2 Comparative Study of Metformin Versus Doxycycline in Moderate to Severe Adult Acne Vulgaris Patients. March 5, 2023 March 2024
NCT05080764 Recruiting Phase 2 Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults December 10, 2021 February 2025
NCT06242288 Recruiting Phase 3 Correlation Between Depression Scores and Serum NF-ĸB/NLRP3 Axis, Biotinidase, and HMGB After Treatment With Isotretinoin in Patients With Acne Vulgaris January 30, 2024 January 20, 2026
NCT06090721 Recruiting Phase 3 DMT310-009 Topical in the Treatment of Acne Vulgaris December 8, 2023 March 30, 2025
NCT06108193 Recruiting Phase 1/Phase 2 Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris July 11, 2023 December 31, 2023
NCT06117293 Recruiting N/A Safety and Efficacy Evaluation of the Mosaic Ultra Device February 21, 2023 September 1, 2025
NCT05891795 Recruiting Phase 1/Phase 2 Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy May 2024 December 2025
NCT00240513 Terminated Phase 4 Study Comparing Acne in Patients Taking Oral Minocycline to Patients Taking Minocycline Plus Topical Tretinoin August 2004 December 2006
NCT01662349 Terminated N/A Safety Study of Plasma Treatment System to Treat Back Acne August 2012 June 2013
NCT00829049 Terminated Phase 4 Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris October 2007 October 2008
NCT03752242 Terminated Phase 2 Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris. January 3, 2019 August 31, 2020
NCT03106766 Terminated Early Phase 1 Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females. March 27, 2017 August 14, 2017
NCT03563365 Terminated Phase 4 The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol June 4, 2018 March 2, 2021
NCT00392223 Terminated Phase 3 Efficacy And Safety Of Azithromycin SR Compared With Minocycline In Acne October 2007 June 2008
NCT02431494 Terminated N/A Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris October 30, 2014 May 12, 2017
NCT02924428 Terminated N/A Venus Versa Diamondpolar Applicator Treatment Followed by AC Dual Applicator Treatment for Facial Acne Vulgaris September 2016 October 2018
NCT00765375 Terminated Phase 2 Safety and Efficacy of the Use of Botox on Acne September 2008 December 2008
NCT05271487 Unknown status N/A A Botanical Skin Care Regimen on Mild to Moderate Acne and the Microbiome March 7, 2022 March 1, 2023
NCT01448733 Unknown status Phase 4 Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris July 2011 October 2011
NCT04870489 Unknown status Phase 2 Combined Treatment With CO2 Laser and Isotretinoin for Acne Scars November 1, 2017 June 1, 2022
NCT03602534 Unknown status Thyroid Dysfunction in Female Patients With Acne Vulgaris: [ Relation to Other Variables ] December 2018 December 2019
NCT05035979 Unknown status Phase 3 Oral Baidi Quzhi Granule Combined With Ju Ying Cream for Acne Vulgaris December 1, 2021 August 31, 2023
NCT05061615 Unknown status Clinico-demographic Features of Patients With Acne Vulgaris October 1, 2021 October 31, 2022
NCT03818555 Unknown status N/A Sebacia Postmarket Study of Real-World Use January 1, 2019 June 2021
NCT01301586 Unknown status Phase 1/Phase 2 A Novel Combination Oral Agent to Treat Acne Vulgaris November 2010 September 2011
NCT03859843 Unknown status Phase 3 Efficacy and Antimicrobial Activity of Platelet Rich Plasma (PRP) in Acne Vulgaris January 10, 2020 May 10, 2022
NCT03866447 Unknown status Phase 4 Role of Vitamin D and Its Topical Analogues in Pathogenesis and Treatment of Acne Vulgaris October 1, 2019 March 1, 2021
NCT03879369 Unknown status Sexual Dysfunction in Female Patients With Adult Acne Vulgaris May 2019 June 2020
NCT03900676 Unknown status Phase 2 Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris April 9, 2019 March 2020
NCT00098358 Unknown status Phase 2 Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne Vulgaris November 2004 May 2005
NCT05186246 Unknown status Phase 1 Effectivity and Safety of Combination of Spent Grain Wax, Argan Oil, Shea Butter and Saccharide Isomerate December 20, 2021 February 28, 2022
NCT04060160 Unknown status Acne Detection Software (AcneDect) October 29, 2020 December 2022
NCT00877409 Unknown status Phase 3 Safety and Efficacy Study of Acnase Creme in the Treatment of Acne Vulgaris I and II April 2009 July 2009
NCT01422785 Unknown status Phase 4 A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne July 2011
NCT05296460 Unknown status Phase 4 DAPSONE GEL7.5%Versus Trichloroacetic Acid 20% ON ACNE VULGARIS September 1, 2022 October 2023
NCT04213638 Unknown status N/A Trial of Single Microneedle Radiofrequency for Moderate-to-Severe Acne Vulgaris November 15, 2019 November 2020
NCT04214483 Unknown status A Pilot Study to Explore the Role of Gut Flora in Acne March 2, 2020 July 2023
NCT01969175 Unknown status N/A Effect of a Low-glycemic-load and Milk-free Diet on Acne Severity October 2013
NCT04224597 Unknown status Evaluation of the Presence of Enthesitis in Patients With Acne Vulgaris February 1, 2020 April 1, 2020
NCT03090048 Unknown status Early Phase 1 Vitamin A and Azithromycin for Acne Vulgaris April 1, 2021 October 31, 2021
NCT04433143 Unknown status N/A Evaluate the Efficacy and Safety of Intense Pulsed Light Filters Combined With Oral Medication in the Treatment of Acne May 15, 2020 May 6, 2021
NCT01260766 Unknown status Phase 2 Acne Treatment With Active Oplon's Patches - 15-18 Years Old January 2011 June 2011
NCT03186222 Unknown status Polymorphism of Extrapituitary Promoter of PRL Gene and Relationships With Serum Prolactin Levels in Acne Vulgaris. January 2018 June 2019
NCT04490967 Unknown status Phase 4 Silymarin Cream Versus Salicylic Acid in Treatment of Acne Vulgaris April 2021 December 2021
NCT03264287 Unknown status N/A Efficacy of Acupuncture Combined With Moving Cupping and Ear Point Tapping for Moderate and Severe Acne Vulgaris September 1, 2017 December 30, 2020
NCT04538703 Unknown status Social Media Use of Acne Vulgaris Patients: Multicenter, Survey Work March 1, 2020 January 30, 2021
NCT00869492 Unknown status Phase 3 Comparison of Nadifloxacin Cream Alone and With Benzoyl Peroxide Solution in the Treatment of Acne August 2008 June 2009
NCT02314039 Unknown status Psychological Factors in Acne: A Focus on Psychological Trauma January 2015 June 2015
NCT04596748 Unknown status N/A Oral Probiotics on the Microbiome and Lipidome in Acne Vulgaris May 11, 2020 March 2021
NCT02395549 Unknown status Phase 2 A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris April 2015 August 2016
NCT03469076 Unknown status N/A Studying the Skin Microbiome and the Potential of a Topical Probiotic Cream for Patients With Acne April 25, 2016 March 31, 2018
NCT03480503 Unknown status Apelin12 in Acne Vulgaris May 2018 December 2019
NCT02491060 Unknown status Phase 3 A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris September 2015 July 2016
NCT04730414 Unknown status Full Spectrum Hemp Observational Study February 2021 December 2021
NCT02525822 Unknown status Phase 2 Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris September 2015 June 2016
NCT02535871 Unknown status Phase 3 A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris September 2015 July 2016
NCT02537483 Unknown status Phase 2 A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris October 2015 September 2016
NCT02100527 Withdrawn Phase 2 Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris April 2014 October 2014
NCT01425320 Withdrawn Phase 1 Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne January 2013 June 2013
NCT02796066 Withdrawn Phase 2 TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris June 2016 February 2017
NCT02716090 Withdrawn Phase 3 Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne Vulgaris
NCT01613924 Withdrawn Phase 4 Efficacy of Handheld Acne Heat Device July 2013 June 2014
NCT04534140 Withdrawn N/A Skin Hydration in Persons With Acne After Dietary Supplementation With Botanical Antioxidants January 25, 2021 January 24, 2023
NCT03707236 Withdrawn N/A The Use of Teledermatology in the Treatment of Patients With Severe Acne on Isotretinoin April 1, 2023 April 1, 2023
NCT00441805 Withdrawn N/A The Treatment of Acne Vulgaris With Radiofrequency Device November 2006 September 2007
NCT04329403 Withdrawn Phase 3 Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1% July 2020 May 2021
NCT00613444 Withdrawn N/A Photodynamic Therapy in the Treatment of Acne February 2008 March 2010
NCT00814918 Withdrawn N/A Topical 5-ALA-PDT With Blu-U Therapy Versus Topical 5-ALA With Pulse Dye Laser In Treating Recalcitrant Acne Vulgaris February 2009 February 2014
NCT03333759 Withdrawn N/A Treatment of Acne Scars With Erbium:Yttrium Aluminum Garnet (Er:YAG) Laser Examined Under OCT August 2018 December 2018
NCT01785836 Withdrawn Phase 1 An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris March 2013 October 2013
NCT03921476 Withdrawn Acne and Mood: Impact of Treatment on Depression, Anxiety, and Sexual Function July 1, 2020 December 31, 2020
NCT02647528 Withdrawn Phase 4 A Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris March 2016 April 2016
NCT03395678 Withdrawn N/A Acne Scarring in Skin of Color: Laser vs Microneedling November 2019 December 2020
ICD10 preferred id (Insert disease from ICD10)
D0009895
ICD10 class code (Insert disease from ICD10)
L70.0
MeSH unique ID (MeSH (Medical Subject Headings))
D000152